// App-Quantinova.ai

OA36 : Treatment of Takayasu’s arteritis with anti-tumour necrosis factor: real world data from a UK tertiary referral centre

Researchers

Presenter

  • Matthew Colquhoun

Principal Investigators

  • Robert Maughan

  • Andrew Porter

  • Japna Satara

  • Samuel Hanlon

  • Jan Nouza

  • Taryn A Youngstein

  • Justin Mason

Medical Centers

  • Haematology Department, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Takayasu arteritis

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolic acid

  • Methotrexate

  • Tocilizumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved